Announcements Trials
Browse Landscape

Phase

Phase 2 1Phase 1/2 1

Status

Terminated 1Completed 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Lymphoid 3Classical hematology 3Other hematologic neoplasm 2Myeloid 2Plasma cell 1CNS 1

Conditions

Leukemia, Myeloid, Acute 176Leukemia 148Myelodysplastic Syndromes 139Precursor Cell Lymphoblastic Leukemia-Lymphoma 113Lymphoma 80Lymphoma, Non-Hodgkin 73Leukemia, Lymphocytic, Chronic, B-Cell 70Hodgkin Disease 64Congenital Abnormalities 63Leukemia, Myeloid, Chronic-Phase 60Multiple Myeloma 58Myeloproliferative Disorders 54Leukemia, Myelomonocytic, Chronic 53Leukemia, Myeloid, Accelerated Phase 53Lymphoma, Large B-Cell, Diffuse 50Lymphoma, Follicular 50Lymphoma, Mantle-Cell 47Burkitt Lymphoma 46Lymphoma, B-Cell, Marginal Zone 45Leukemia, Myelogenous, Chronic, BCR-ABL Positive 45Blast Crisis 44Lymphoma, Large-Cell, Immunoblastic 43Anemia, Refractory, with Excess of Blasts 43Neoplasms, Plasma Cell 41Hematologic Neoplasms 35Graft vs Host Disease 35Primary Myelofibrosis 33Myelodysplastic-Myeloproliferative Diseases 33Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative 32Dendritic Cell Sarcoma, Interdigitating 32

Interventions

fludarabine phosphate 4fludarabine 3Whole-Body Irradiation 3Thiotepa 3Melphalan 3Cyclophosphamide 3Therapeutics 2Busulfan 2Antilymphocyte Serum 2Alemtuzumab 2thymoglobulin 1fosphenytoin 1Vaccination 1Photopheresis 1Phenytoin 1Peripheral Blood Stem Cell Transplantation 1Injections 1Clofarabine 1Clinical Trials, Phase I as Topic 1Bone Marrow Transplantation 1Blood Specimen Collection 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Immunologic Deficiency Syndromes × Busulfan × Other hematologic neoplasm × Clear all
NCT00801931 2019-03-27

Double Cord Blood Transplant for Patients With Malignant and Non-malignant Disorders

Columbia University

Phase 1/2 Terminated
1 enrolled 8 charts
CNSClassical hematologyLymphoidOther hematologic neoplasm

Anemia, Immunologic Deficiency Syndromes, Leukemia, Lymphoma, Neuroblastoma

NCT01049854 2018-08-21

CD34+Selection for Partially Matched Family or Matched Unrelated Adult Donor Transplant

New York Medical College

Phase 2 Completed
20 enrolled
Classical hematologyLymphoidMyeloidOther hematologic neoplasm

Bone Marrow Failure Disorders, Anemia, Sickle Cell, Immunologic Deficiency Syndromes, Leukemia, Lymphoma, Metabolism, Inborn Errors, Histiocytosis, beta-Thalassemia

Data powered by HemOnc (CC BY 4.0) Colophon âš¡